• Profile
Close

Clopidogrel therapy in patients with cardiovascular disease undergoing transurethral resection of the prostate: A step towards individualization

Drugs & Aging Dec 01, 2017

Tzimas P, et al. - This research was designed to examine platelet function pre- and peri-operatively in clopidogrel-treated patients undergoing transurethral resection of the prostate. The physicians revealed that platelet activation was similar 3 and 7 days from clopidogrel cessation, in patients undergoing transurethral resection of the prostate. These outcomes could be of relevance in subjects at increased thrombotic risk prior to a surgical procedure carrying a high-bleeding risk.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay